BTS: Should Everyone Be Induced at 39 Weeks?
About this episode
The episode discusses the ARRIVE trial and its implications for elective induction at 39 weeks for low-risk first-time mothers.
In this episode of Baby Tribe Shorts, Afif and Anne take a closer look at one of the most influential obstetric studies of the last decade: the ARRIVE trial. The trial is often used in conversations about elective induction at 39 weeks, especially for low-risk first-time mothers. But what did it actually show? Did induction improve outcomes for babies? Did it really reduce C-section rates? And what happens when the findings of a carefully controlled clinical trial are applied to busy real-wor...
People in this episode
Hosts: Afif EL-Khuffash, Anne Doherty
Topics covered
- induction
- obstetric studies
- ARRIVE trial
- low-risk mothers
- C-section rates
Mentioned in this episode
Books & works: ARRIVE trial
More episodes of The Baby Tribe
- BTS: Is Private Maternity Care Really Safer?
- BTS: Paracetamol, Pregnancy and Autism: What Parents Need to Know
- 134: Baby Gadgets, Gimmicks and Red Flags
- 133: The Freebirth Movement: Choice, Risk and Accountability
- 132: Bad Science in a Pretty Font - Caesareans, Risk and Birth Misinformation
- 131: Alcohol, Pregnancy and Breastfeeding: No Shame, No Myths, Just Biology
Explore listener stats, chart rankings, contacts and more on the The Baby Tribe podcast page.